Compare CIVB & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CIVB | THW |
|---|---|---|
| Founded | 1884 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 591.5M | 516.7M |
| IPO Year | 2012 | 2015 |
| Metric | CIVB | THW |
|---|---|---|
| Price | $28.76 | $13.34 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $26.60 | N/A |
| AVG Volume (30 Days) | 156.3K | ★ 160.9K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 31.34 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $19,023,000.00 | N/A |
| Revenue This Year | $14.88 | N/A |
| Revenue Next Year | $5.99 | N/A |
| P/E Ratio | $39.65 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.95 | $10.17 |
| 52 Week High | $29.38 | $13.79 |
| Indicator | CIVB | THW |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 54.73 |
| Support Level | $26.21 | $12.33 |
| Resistance Level | $29.38 | $13.79 |
| Average True Range (ATR) | 0.82 | 0.23 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 75.62 | 34.19 |
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.